Showing results (71-80 of 114) with videos related to
Sort By:
Pageof 12
Plos One|December 3, 2015
Pulmonary Hypertension in Patients with Chronic Fibrosing Idiopathic Interstitial PneumoniasMarius M Hoeper, Juergen Behr, Matthias Held, et al.The European Respiratory Journal|August 30, 2022
Sotatercept for the treatment of pulmonary arterial hypertension: PULSAR open-label extensionMarc Humbert, Vallerie McLaughlin, J Simon R Gibbs, et al.Journal of the American College of Cardiology|July 23, 2016
Pre-Capillary, Combined, and Post-Capillary Pulmonary Hypertension: A Pathophysiological ContinuumChristian F Opitz, Marius M Hoeper, J Simon R Gibbs, et al.The European Respiratory Journal|August 5, 2017
Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification modelMarius M Hoeper, Tilmann Kramer, Zixuan Pan, et al.The Lancet. Respiratory Medicine|June 19, 2017
Plasma proteome analysis in patients with pulmonary arterial hypertension: an observational cohort studyChristopher J Rhodes, John Wharton, Pavandeep Ghataorhe, et al.The New England Journal of Medicine|March 31, 2021
Sotatercept for the Treatment of Pulmonary Arterial HypertensionMarc Humbert, Vallerie McLaughlin, J Simon R Gibbs, et al.Pulmonary Circulation|May 11, 2013
Supplementation of iron in pulmonary hypertension: Rationale and design of a phase II clinical trial in idiopathic pulmonary arterial hypertensionLuke S G E Howard, Geoffrey M J Watson, John Wharton, et al.Circulation|February 8, 2014
Aberrant chloride intracellular channel 4 expression contributes to endothelial dysfunction in pulmonary arterial hypertensionBeata Wojciak-Stothard, Vahitha B Abdul-Salam, Ka Hou Lao, et al.American Journal of Respiratory and Critical Care Medicine|February 23, 2008
Improved outcomes in medically and surgically treated chronic thromboembolic pulmonary hypertensionRobin Condliffe, David G Kiely, J Simon R Gibbs, et al.American Journal of Respiratory and Critical Care Medicine|March 4, 2025
Consistent Safety and Efficacy of Sotatercept for Pulmonary Arterial Hypertension in <i>BMPR2</i> Mutation Carriers and Noncarriers: A Planned Analysis of a Phase II, Double-Blind, Placebo-controlled Clinical Trial (PULSAR)David Montani, Vallerie V McLaughlin, J Simon R Gibbs, et al.Pageof 12